As of 2026-10-05, the Relative Valuation of Alpine Immune Sciences Inc (ALPN) is (14.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 64.97 USD, the upside of Alpine Immune Sciences Inc based on Relative Valuation is -122.5%.
The range of the Relative Valuation is (12.61) - (18.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 34.0x | 27.0x |
| Forward P/E multiples | 23.2x - 34.5x | 27.4x |
| Fair Price | (12.61) - (18.25) | (14.61) |
| Upside | -119.4% - -128.1% | -122.5% |
| Date | P/E |